Literature DB >> 21528237

Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines.

A Urtreger, V Ladeda, L Puricelli, A Rivelli, M Vidal, E Delustig, E Joffe.   

Abstract

Two cell lines obtained by sequential subcultures from primary cultures of the murine mammary adenocarcinomas M3 and MM3 were characterized. During LM3 cell line evolution an increase in the anchorage-independent growth ability, a displacement towards a triploid level in the chromosomic distribution and a loss of fibronectin (FN) expression were observed. LMM3 cell line showed a tetraploid chromosomic number and was unable to produce FN, behaving in a similar way as its parental tumor MM3. The local invasive ability as well as the spontaneous metastatic capacity of LM3 cells inoculated subcutaneously (s.c.) increased with the passage number and were associated with the progressive loss of FN expression as well as to the appearence of membrane bound uPA. LMM3 cells, which did not express FN, maintained the high spontaneous metastasic capacity already shown by the parental tumor MM3 but acquired a higher local invasive phenotype.

Entities:  

Year:  1997        PMID: 21528237     DOI: 10.3892/ijo.11.3.489

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  22 in total

1.  Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.

Authors:  Dolores Fernández; Macarena Guereño; María Amparo Lago Huvelle; Magalí Cercato; María Giselle Peters
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-28       Impact factor: 4.553

2.  Fibronectin is chemotactic for CT 26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization.

Authors:  L Geng; S A Ali; J F Marshall; C L Mackay; I R Hart; M Delcommence; C H Streuli; R C Rees
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

3.  Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model.

Authors:  Melisa B Nicoud; Mónica A Táquez Delgado; María de la Paz Sarasola; Agustina Vidal; Daniela Speisky; Graciela A Cremaschi; Helena A Sterle; Vanina A Medina
Journal:  Cancer Immunol Immunother       Date:  2020-07-22       Impact factor: 6.968

4.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

5.  Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.

Authors:  L Venturutti; L V Romero; A J Urtreger; M F Chervo; R I Cordo Russo; M F Mercogliano; G Inurrigarro; M G Pereyra; C J Proietti; F Izzo; M C Díaz Flaqué; V Sundblad; J C Roa; P Guzmán; E D Bal de Kier Joffé; E H Charreau; R Schillaci; P V Elizalde
Journal:  Oncogene       Date:  2015-07-27       Impact factor: 9.867

6.  Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic Acid.

Authors:  Andrea Comba; Luciana L Almada; Ezequiel J Tolosa; Eriko Iguchi; David L Marks; Marianela Vara Messler; Renata Silva; Maite G Fernandez-Barrena; Elisa Enriquez-Hesles; Anne L Vrabel; Bruno Botta; Lucia Di Marcotulio; Volker Ellenrieder; Aldo R Eynard; Maria E Pasqualini; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

7.  Novel meso-substituted porphyrin derivatives and its potential use in photodynamic therapy of cancer.

Authors:  Pablo Vallecorsa; Gabriela Di Venosa; M Belén Ballatore; Dario Ferreyra; Leandro Mamone; Daniel Sáenz; Gustavo Calvo; Edgardo Durantini; Adriana Casas
Journal:  BMC Cancer       Date:  2021-05-13       Impact factor: 4.430

8.  Antineoplastic activity of products derived from cellulose-containing materials: levoglucosenone and structurally-related derivatives as new alternatives for breast cancer treatment.

Authors:  Damian Ignacio Delbart; German Francisco Giri; Agostina Cammarata; Melisan Denise Pan; Lizeth Ariza Bareño; Natalia Loreley Amigo; Andrés Bechis; Alejandra Graciela Suarez; Rolando Ángel Spanevello; Marcela Solange Villaverde; Laura Beatriz Todaro; Alejandro Jorge Urtreger
Journal:  Invest New Drugs       Date:  2021-09-03       Impact factor: 3.850

9.  Autoantibodies against muscarinic receptors in breast cancer: their role in tumor angiogenesis.

Authors:  María Gabriela Lombardi; María Pía Negroni; Laura Tatiana Pelegrina; María Ester Castro; Gabriel L Fiszman; María Eugenia Azar; Carlos Cresta Morgado; María Elena Sales
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

10.  Photodynamic Therapy of the Murine LM3 Tumor Using Meso-Tetra (4-N,N,N-Trimethylanilinium) Porphine.

Authors:  L L Colombo; A Juarranz; M Cañete; A Villanueva; J C Stockert
Journal:  Int J Biomed Sci       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.